Valsartan - Taking potassium citrate 1080 mlg 3x day, and Diovan 160. Should I be concerned?
- Posted:
- 17 Jun 2009 by diedra
- Topics:
- diovan, high blood pressure, potassium citrate
Answers (1)
18 Jun 2009
There is an interaction between these two drugs which warns that taking valsartan and potassium citrate together may increase the risk of hyperkalemia (too much potassium in the blood.) If this combination has been prescribed by your doctor, you should be getting your potassium levels monitored.
You need to be aware of foods that contain potassium (see http://www.drugs.com/cg/potassium-content-of-foods-list.html) and make sure you do not use potassium-containing salt substitutes without consulting your doctor.
See your doctor if you experience symptoms of hyperkalemia such as weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Similar questions
Are there any food restrictions with Diovan, regarding potassium?
Fruits and vegetables are high in potassium and form a big part of a healthy diet. My doctor said to avoid bananas. But almost all good food contain ...
Does Diovan appy equal and opposite force to prevent blood pressure from going too high OR does?
... diovan just force blood pressure lower? My point regarding equal and opposite force would imply that if the blood pressure is not high, the drug ...
I have had eleal pouch reconstruction and take Potassium Citrate?
The pills I take do not desolve when passed through the system. Am I getting the whole effect of the potassium cit. (1080 MG )
High Blood Pressure - if I was on olmesartan medoxomil 20mg and was switched to valsartan 160mg, is?
... this similar or stronger?
Exforge and diovan are they the same? you can't find the ingredients in bp meds?
best info i can find seems exforge,amiodipine,and valsartan are exforge. starting with the first pill I took I became a zombie. It affected every ...
